We aimed to study the impact of altered thyroid status on myocardial expression of electrical coupling protein connexin-43 (Cx43), the susceptibility of rats to ventricular fibrillation (VF) and the effects of antioxidant-rich red palm oil (RPO). Adult male and female euthyroid, hyperthyroid (treated with T3/T4), hypothyroid (treated with methimazole) Wistar rats supplemented or not with RPO for 6 weeks were used. Function of isolated perfused heart and VF threshold were determined. Left ventricular tissue was used for assessment of mRNA and protein levels of Cx43, its phosphorylated forms and topology. Protein kinase C signaling (PKC) and gene transcripts of some proteins related to cardiac arrhythmias were assessed. Hyperthyroid state resulted in decrease of total and phosphorylated forms of Cx43 and suppression of PKC-ε expression in males and females, decrease of Cx43 mRNA in females, decrease of VF threshold and increase of functional parameters in male rat hearts. In contrast, hypothyroid status resulted in the increase of total and phosphorylated forms of Cx43, enhancement PKC-ε expression in males and females, increase of Cx43 mRNA in females, increase of VF threshold and decrease of functional parameters in male rat hearts. Function of the heart was partially normalized by RPO intake, which also enhanced myocardial Cx43 and PKC-ε expression as well as increased VF threshold in hyperthyroid male rats. We conclude that there is an inverse relationship between myocardial expression of Cx43, including its functional phosphorylated forms, and susceptibility of male rat hearts to VF in condition of altered thyroid status. RPO intake partly ameliorated adverse changes caused by excess of thyroid hormones.

Department of Physiology Faculty of Science Charles University Prague Czech Republic

Institute for Heart Research Slovak Academy of Sciences Dúbravská cesta 9 POBox 104 840 05 Bratislava Slovak Republic

Institute of Experimental Pharmacology and Toxicology SAS Bratislava Slovak Republic

Institute of Physiology v v i Academy of Sciences of the Czech Republic Prague Czech Republic

Zobrazit více v PubMed

Pflugers Arch. 2009 Oct;458(6):1061-8 PubMed

Physiol Res. 2005;54(6):705-8 PubMed

Endocrinology. 2009 Jan;150(1):546-54 PubMed

Circ Res. 1996 Sep;79(3):388-98 PubMed

J Hypertens. 2013 Sep;31(9):1876-85 PubMed

J Mol Cell Cardiol. 1995 Aug;27(8):1731-43 PubMed

J Clin Endocrinol Metab. 2000 Dec;85(12):4701-5 PubMed

Horm Metab Res. 2013 Jul;45(7):507-12 PubMed

Biochim Biophys Acta. 2005 Dec 20;1719(1-2):36-58 PubMed

Exp Physiol. 1998 Nov;83(6):763-70 PubMed

Can J Physiol Pharmacol. 2013 Aug;91(8):633-9 PubMed

Physiol Res. 2008;57 Suppl 2:S91-6 PubMed

Mol Cell Biochem. 1996 Apr 12-26;157(1-2):93-9 PubMed

Physiol Res. 2014;63 Suppl 1:S119-31 PubMed

Med Princ Pract. 2013;22(1):42-6 PubMed

Horm Metab Res. 2011 Jan;43(1):43-7 PubMed

Physiol Res. 2008;57 Suppl 2:S1-S13 PubMed

Physiol Res. 2013;62(4):445-53 PubMed

Int J Biochem Cell Biol. 2010 Nov;42(11):1767-70 PubMed

Circ Res. 2000 Apr 14;86(7):723-8 PubMed

Exp Physiol. 2004 Sep;89(5):629-36 PubMed

Mol Cell Biochem. 1993 Dec 22;129(2):145-59 PubMed

Heart Fail Rev. 2015 May;20(3):273-82 PubMed

J Mol Histol. 2004 Jun;35(5):463-70 PubMed

J Clin Invest. 2010 Jan;120(1):266-79 PubMed

J Physiol Pharmacol. 2008 Jun;59(2):271-85 PubMed

Histochem Cell Biol. 2014 Dec;142(6):677-84 PubMed

Physiol Res. 2014;63 Suppl 1:S133-40 PubMed

J Appl Physiol (1985). 2015 Dec 15;119(12 ):1487-93 PubMed

Thyroid. 2002 Jun;12(6):447-52 PubMed

Circ Res. 1981 Jul;49(1):1-15 PubMed

Life Sci. 2004 Jul 9;75(8):923-31 PubMed

Circulation. 2005 Nov 15;112(20):3122-30 PubMed

Cardiovasc Res. 1998 Nov;40(2):343-51 PubMed

Mol Cell Biochem. 2011 Jul;353(1-2):235-41 PubMed

J Physiol Pharmacol. 2015 Feb;66(1):83-9 PubMed

Physiol Res. 2001;50(6):619-26 PubMed

Physiol Res. 2008;57 Suppl 2:S39-48 PubMed

Adv Cardiol. 2006;42:243-54 PubMed

Cardiovasc Drugs Ther. 2006 Dec;20(6):463-9 PubMed

J Electrocardiol. 2015 May-Jun;48(3):434-40 PubMed

Vascul Pharmacol. 2010 Mar-Apr;52(3-4):102-12 PubMed

Distinct Cardiac Connexin-43 Expression in Hypertrophied and Atrophied Myocardium May Impact the Vulnerability of the Heart to Malignant Arrhythmias. A Pilot Study

Anti-Fibrotic Potential of Angiotensin (1-7) in Hemodynamically Overloaded Rat Heart

Cardiac Cx43 Signaling Is Enhanced and TGF-β1/SMAD2/3 Suppressed in Response to Cold Acclimation and Modulated by Thyroid Status in Hairless SHRM

Antiarrhythmic Effects of Melatonin and Omega-3 Are Linked with Protection of Myocardial Cx43 Topology and Suppression of Fibrosis in Catecholamine Stressed Normotensive and Hypertensive Rats

Cardiac Cx43 and ECM Responses to Altered Thyroid Status Are Blunted in Spontaneously Hypertensive versus Normotensive Rats

Obesity-associated alterations in cardiac connexin-43 and PKC signaling are attenuated by melatonin and omega-3 fatty acids in female rats

Anti-arrhythmic Cardiac Phenotype Elicited by Chronic Intermittent Hypoxia Is Associated With Alterations in Connexin-43 Expression, Phosphorylation, and Distribution